| NCT06680258 | A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy | NOT_YET_RECRUITING | PHASE3 | 2025-12 | 2030-07 | 2028-12 |
| NCT04344795 | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors | COMPLETED | PHASE1 | 2020-05-06 | 2024-09-25 | 2024-09-25 |
| NCT03829436 | TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers | COMPLETED | PHASE1 | 2019-03-20 | 2022-09-07 | 2022-09-07 |